Co-localization of cortactin and phosphotyrosine identifies active invadopodia in human breast cancer cells.

Invadopodia are filopodia-like projections possessing protease activity that participate in tumor cell invasion. We demonstrate that co-localization of cortactin and phosphotyrosine identifies a subset of cortactin puncta termed "invadopodial complexes" that we find to be closely associated with the plasma membrane at active sites of focal degradation of the extracellular matrix in MDA-MB-231 breast cancer cells. Manipulation of c-Src activity in cells by transfection with kinase activated c-Src(527) or kinase inactive c-Src(295) results in a dramatic increase or decrease, respectively, in the number of these structures associated with changes in the number of sites of active matrix degradation. Overexpression of kinase-inactive c-Src(295) does not prevent localization of cortactin at the membrane; however, co-localized phosphotyrosine staining is decreased. Thus, elevated phosphotyrosine at invadopodial complexes is specifically associated with the proteolytic activity of invadopodia. Further, invadopodial complexes are spatially, morphologically and compositionally distinct from focal adhesions as determined by localization of focal adhesion kinase (FAK), which is not present in invadopodial complexes. Expression of kinase-inactive c-Src(295) blocks invadopodia activity, but does not block filopodia formation. Thus, invadopodia, but not filopodia, are highly correlated with matrix invasion, and sites of invadopodial activity can be identified by the formation of invadopodial complexes.

[1]  P. Coopman,et al.  Integrin alpha 3 beta 1 participates in the phagocytosis of extracellular matrix molecules by human breast cancer cells. , 1996, Molecular biology of the cell.

[2]  J. Olivo-Marin,et al.  Cortactin and Crk cooperate to trigger actin polymerization during Shigella invasion of epithelial cells , 2004, The Journal of cell biology.

[3]  S. Akiyama,et al.  A Novel Protease-docking Function of Integrin at Invadopodia* , 1999, The Journal of Biological Chemistry.

[4]  T. Kmiecik,et al.  Activation and suppression of pp60c-src transforming ability by mutation of its primary sites of tyrosine phosphorylation , 1987, Cell.

[5]  C. Haudenschild,et al.  Cortactin potentiates bone metastasis of breast cancer cells. , 2001, Cancer research.

[6]  J. Sellers Regulation of cytoplasmic and smooth muscle myosin. , 1991, Current opinion in cell biology.

[7]  P. Friedl,et al.  Proteolytic and non-proteolytic migration of tumour cells and leucocytes. , 2003, Biochemical Society symposium.

[8]  S. Lin,et al.  Differentiation dependent expression of tensin and cortactin in chicken osteoclasts. , 1995, Cell motility and the cytoskeleton.

[9]  S. Zucker,et al.  A Conserved Sequence within the Propeptide Domain of Membrane Type 1 Matrix Metalloproteinase Is Critical for Function as an Intramolecular Chaperone* , 2002, The Journal of Biological Chemistry.

[10]  J. Parsons,et al.  Identification and characterization of a novel cytoskeleton-associated pp60src substrate , 1991, Molecular and cellular biology.

[11]  P. De Camilli,et al.  A Functional Link between Dynamin and the Actin Cytoskeleton at Podosomes , 2000, The Journal of cell biology.

[12]  H. Petty,et al.  Molecular proximity of seprase and the urokinase-type plasminogen activator receptor on malignant melanoma cell membranes: dependence on beta1 integrins and the cytoskeleton. , 2002, Carcinogenesis.

[13]  W. T. Chen,et al.  Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadopodia is required for cell invasion. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[14]  E. Thompson,et al.  Phagocytosis of cross-linked gelatin matrix by human breast carcinoma cells correlates with their invasive capacity. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[15]  K. Somers,et al.  Overexpression of EMS1/cortactin in NIH3T3 fibroblasts causes increased cell motility and invasion in vitro , 1998, Oncogene.

[16]  E. Schuuring,et al.  The product of the EMS1 gene, amplified and overexpressed in human carcinomas, is homologous to a v-src substrate and is located in cell-substratum contact sites , 1993, Molecular and cellular biology.

[17]  G. W. Snedecor Statistical Methods , 1964 .

[18]  W. T. Chen,et al.  Proteolytic activity of specialized surface protrusions formed at rosette contact sites of transformed cells. , 1989, The Journal of experimental zoology.

[19]  Z. Werb,et al.  Focalized proteolysis: spatial and temporal regulation of extracellular matrix degradation at the cell surface. , 1996, Current opinion in cell biology.

[20]  M. Aepfelbacher,et al.  Podosomes: adhesion hot-spots of invasive cells. , 2003, Trends in cell biology.

[21]  L. Bourguignon,et al.  CD44 Interaction with c-Src Kinase Promotes Cortactin-mediated Cytoskeleton Function and Hyaluronic Acid-dependent Ovarian Tumor Cell Migration* , 2001, The Journal of Biological Chemistry.

[22]  T. Kelly,et al.  Proteolysis of extracellular matrix by invadopodiafacilitates human breast cancer cell invasion and ismediated by matrix metalloproteinases , 1998, Clinical & Experimental Metastasis.

[23]  D. Thomas,et al.  An invasion-related complex of cortactin, paxillin and PKCμ associates with invadopodia at sites of extracellular matrix degradation , 1999, Oncogene.

[24]  M. Kogo,et al.  Involvement of Cdc42 and Rac small G proteins in invadopodia formation of RPMI7951 cells , 2003, Genes to cells : devoted to molecular & cellular mechanisms.

[25]  D. Schlaepfer,et al.  v-Src SH3-enhanced Interaction with Focal Adhesion Kinase at β1 Integrin-containing Invadopodia Promotes Cell Invasion* , 2002, The Journal of Biological Chemistry.

[26]  P. Coopman,et al.  Invadopodia: unique methods for measurement of extracellular matrix degradation in vitro. , 2001, Methods in cell biology.

[27]  J. Brugge,et al.  Isolation of monoclonal antibodies that recognize the transforming proteins of avian sarcoma viruses , 1983, Journal of virology.

[28]  C. Haudenschild,et al.  The Role of Tyrosine Phosphorylation of Cortactin in the Locomotion of Endothelial Cells* , 1998, The Journal of Biological Chemistry.

[29]  S. Colucci,et al.  Osteoclast cytosolic calcium, regulated by voltage-gated calcium channels and extracellular calcium, controls podosome assembly and bone resorption , 1990, The Journal of cell biology.

[30]  W. T. Chen,et al.  A potential marker protease of invasiveness, seprase, is localized on invadopodia of human malignant melanoma cells. , 1994, Cancer research.

[31]  M. Gimona,et al.  Actin cytoskeleton remodelling via local inhibition of contractility at discrete microdomains , 2004, Journal of Cell Science.

[32]  D. Shalloway,et al.  Altered tyrosine 527 phosphorylation and mitotic activation of p60c-src , 1991, Nature.

[33]  W. T. Chen,et al.  Tyrosine phosphorylation of membrane proteins mediates cellular invasion by transformed cells , 1992, The Journal of cell biology.

[34]  A. Zallone,et al.  Clear zone in osteoclast function: role of podosomes in regulation of bone-resorbing activity. , 1991, The American journal of physiology.

[35]  M. Nomizu,et al.  Activation of β1 Integrin Signaling Stimulates Tyrosine Phosphorylation of p190 RhoGAP and Membrane-protrusive Activities at Invadopodia* , 1998, The Journal of Biological Chemistry.

[36]  Roberto Buccione,et al.  Foot and mouth: podosomes, invadopodia and circular dorsal ruffles , 2004, Nature Reviews Molecular Cell Biology.

[37]  Robert Clarke,et al.  Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines , 1992, Journal of cellular physiology.

[38]  W. T. Chen,et al.  Binding and localization of M(r) 72,000 matrix metalloproteinase at cell surface invadopodia. , 1993, Cancer research.

[39]  M. Resh,et al.  p80/85 Cortactin Associates with the Src SH2 Domain and Colocalizes with v-Src in Transformed Cells (*) , 1995, The Journal of Biological Chemistry.

[40]  Yoshihiko Yamada,et al.  A Mechanism for Regulation of Melanoma Invasion , 1996, The Journal of Biological Chemistry.

[41]  R. Cardiff,et al.  CD44v3,8–10 is involved in cytoskeleton‐mediated tumor cell migration and matrix metalloproteinase (MMP‐9) association in metastatic breast cancer cells , 1998 .

[42]  Yamei Gao,et al.  Down-regulation of the Filamentous Actin Cross-linking Activity of Cortactin by Src-mediated Tyrosine Phosphorylation* , 1997, The Journal of Biological Chemistry.

[43]  J. Resau,et al.  The adaptor protein Tks5/Fish is required for podosome formation and function, and for the protease-driven invasion of cancer cells. , 2005, Cancer cell.

[44]  J. Parsons,et al.  Cortactin, an 80/85-kilodalton pp60src substrate, is a filamentous actin-binding protein enriched in the cell cortex , 1993, The Journal of cell biology.

[45]  W. T. Chen,et al.  Invadopodia promote proteolysis of a wide variety of extracellular matrix proteins , 1994, Journal of cellular physiology.

[46]  M. Kaksonen,et al.  Cortactin-Src Kinase Signaling Pathway Is Involved in N-syndecan-dependent Neurite Outgrowth* , 1998, The Journal of Biological Chemistry.

[47]  W. T. Chen,et al.  Cellular invasion into matrix beads: localization of beta 1 integrins and fibronectin to the invadopodia. , 1991, Journal of cell science.

[48]  M. McNiven,et al.  The role of dynamin in the assembly and function of podosomes and invadopodia. , 2004, Frontiers in bioscience : a journal and virtual library.

[49]  I. Pass,et al.  The Adaptor Protein Fish Associates with Members of the ADAMs Family and Localizes to Podosomes of Src-transformed Cells* , 2003, The Journal of Biological Chemistry.

[50]  Alissa M. Weaver,et al.  Cortactin Localization to Sites of Actin Assembly in Lamellipodia Requires Interactions with F-Actin and the Arp2/3 Complex , 2000, The Journal of cell biology.

[51]  J. Dodt,et al.  Identification of the 170-kDa Melanoma Membrane-bound Gelatinase (Seprase) as a Serine Integral Membrane Protease* , 1997, The Journal of Biological Chemistry.